| Status | Study |
| Recruiting |
Study Name: Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A Condition: Acquired Hemophilia A Date: 2015-10-29 Interventions: Biological: OBIZUR Treating physician will determine treatment regimen, frequency of laboratory and clin |
| No longer available |
Study Name: Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies Condition: Acquired Hemophilia A Date: 2013-10-21 Interventions: Biological: OBI-1 Other Name: B-Domain Deleted Recombinant Porcine Factor VIII |
| Completed |
Study Name: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A Condition: Hemophilia A Date: 2010-08-06 Interventions: Biological: OBI-1 Intravenous infusion |
| Terminated |
Study Name: Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A Condition: Hemophilia A Date: 2006-03-23 Interventions: Drug: Rituxan Acquired Hemophi |